{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:05:41Z","timestamp":1785477941698,"version":"3.56.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.mcna.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T06:35:34Z","timestamp":1619505334000},"page":"511-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neuro-Ophthalmology for Internists"],"prefix":"10.1016","volume":"105","author":[{"given":"Neena R.","family":"Cherayil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura A.","family":"Tamhankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.01.005_bib1","author":"Liu"},{"key":"10.1016\/j.mcna.2021.01.005_bib2","author":"Tamhankar"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/IAE.0b013e31829234b5","article-title":"Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses","volume":"34","author":"Hayreh","year":"2014","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/eye.2016.199","article-title":"Ophthalmic presentation of giant cell arteritis in African-Americans","volume":"31","author":"Garrity","year":"2017","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0161-6420(01)00574-7","article-title":"The epidemiology of giant cell arteritis: a 12-year retrospective study","volume":"108","author":"Liu","year":"2001","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.mcna.2021.01.005_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.mcna.2021.01.005_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","article-title":"Arteries of the head and neck in giant cell arteritis: a pathological study to show the pattern of arterial involvement","volume":"27","author":"Wilkinson","year":"1972","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.mcna.2021.01.005_bib11","series-title":"Ischemic optic neuropathies","first-page":"199","article-title":"Ophthalmic manifestations of giant cell arteritis","author":"Hayreh","year":"2011"},{"issue":"8","key":"10.1016\/j.mcna.2021.01.005_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/head.12425","article-title":"Giant cell arteritis","volume":"54","author":"Smith","year":"2014","journal-title":"Headache J Head Face Pain"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNO.0000000000000656","article-title":"Retrospective, multicenter comparison of the clinical presentation of patients presenting with diplopia from giant cell arteritis vs other causes.","volume":"39","author":"Ross","year":"2019","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9394(14)70123-0","article-title":"Giant cell arteritis: validity and reliability of various diagnostic criteria","volume":"123","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","article-title":"Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy","volume":"118","author":"Walvick","year":"2011","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.mcna.2021.01.005_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00041327-200020020-00001","article-title":"Thrombocytosis in temporal arteritis: rising platelet counts: a red flag for giant cell arteritis","volume":"20","author":"Lincoff","year":"2000","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.mcna.2021.01.005_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijso.2017.09.003","article-title":"The 2016 revised ACR criteria for diagnosis of giant cell arteritis \u2013 our case series: can this avoid unnecessary temporal artery biopsies?","volume":"9","author":"Sait","year":"2017","journal-title":"Int J Surg Open"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11940-017-0440-y","article-title":"The treatment of giant cell arteritis","volume":"19","author":"Jivraj","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.mcna.2021.01.005_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-11-44","article-title":"The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis","volume":"11","author":"Arida","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kex173","article-title":"The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"issue":"9","key":"10.1016\/j.mcna.2021.01.005_bib23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3174\/ajnr.A0638","article-title":"Diagnostic value of high-resolution MR imaging in giant cell arteritis","volume":"28","author":"Bley","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.mcna.2021.01.005_bib24","author":"Pineles"},{"issue":"21","key":"10.1016\/j.mcna.2021.01.005_bib25","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/01.wnl.0000475335.63503.86","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"85","author":"Lavi","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00041327-199403000-00011","article-title":"Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy: population-based study in the state of Missouri and Los Angeles County, California","volume":"14","author":"Johnson","year":"1994","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"11","key":"10.1016\/j.mcna.2021.01.005_bib27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archopht.1996.01100140566007","article-title":"Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the ischemic optic neuropathy decompression trial","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9394(14)77911-5","article-title":"Clinical profile and long-term implications of anterior ischemic optic neuropathy","volume":"96","author":"Repka","year":"1983","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/WNO.0000000000000552","article-title":"Role of nocturnal arterial hypotension in nonarteritic anterior ischemic optic neuropathy. [Letter]","volume":"37","author":"Hayreh","year":"2017","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"10.1016\/j.mcna.2021.01.005_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaophthalmol.2015.0893","article-title":"Association of nonarteritic ischemic optic neuropathy with obstructive sleep apnea syndrome: consequences for obstructive sleep apnea screening and treatment","volume":"133","author":"Aptel","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0002-9394(14)72557-7","article-title":"Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy","volume":"118","author":"Hayreh","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib33","first-page":"143","article-title":"Nonarteritic anterior ischemic optic neuropathy and obstructive sleep apnea\/a prospective photographic study of the ocular fundus in obstructive sleep apnea","volume":"23","author":"O\u2019Sullivan","year":"2013","journal-title":"Curr Med Lit Ophthalmol"},{"issue":"5","key":"10.1016\/j.mcna.2021.01.005_bib34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)70902-X","article-title":"Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(02)01639-2","article-title":"The fellow eye in NAION: report from the Ischemic Optic Neuropathy Decompression Trial follow-up study","volume":"134","author":"Newman","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.mcna.2021.01.005_bib36","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis: experience of the optic neuritis treatment trial","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00417-007-0722-2","article-title":"Visual field defects in acute optic neuritis - distribution of different types of defect pattern, assessed with threshold-related supraliminal perimetry, ensuring high spatial resolution","volume":"246","author":"Nevalainen","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years","volume":"128","author":"Keltner","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.mcna.2021.01.005_bib39","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0161-6420(03)00477-9","article-title":"Optic neuritis: correlation of pain and magnetic resonance imaging","volume":"110","author":"Fazzone","year":"2003","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.mcna.2021.01.005_bib40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archneur.1993.00540080050013","article-title":"Brain magnetic resonance imaging in acute optic neuritis: experience of the optic neuritis study group","volume":"50","author":"Beck","year":"1993","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.mcna.2021.01.005_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A\u00a0randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mcna.2021.01.005_bib43","author":"Gout"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","year":"2016","journal-title":"J\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4\u2013IgG in patients in the Optic Neuritis Treatment Trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.mcna.2021.01.005_bib46","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum: aquaporin-4-IgG seroprevalence","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mcna.2021.01.005_bib47","author":"Gobel"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1526-4610.2007.00978.x","article-title":"Expert opinion: retinal migraine: migraine associated with monocular visual symptoms (CME)","volume":"48","author":"Evans","year":"2008","journal-title":"Headache J Head Face Pain"},{"issue":"7","key":"10.1016\/j.mcna.2021.01.005_bib49","first-page":"1889","article-title":"Patterns of non-embolic transient monocular visual field loss","volume":"260","author":"Petzold","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"1 Supplement","key":"10.1016\/j.mcna.2021.01.005_bib50","article-title":"Minimum conditions for the induction of cortical spreading depression: implications for migraine with Aura (S16.002)","volume":"78","author":"Brennan","year":"2012","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mcna.2021.01.005_bib51","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1212\/01.wnl.0000183281.12779.cd","article-title":"Leao\u2019s cortical spreading depression: from experimental \u201cartifact\u201d to physiological principle","volume":"65","author":"Teive","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2021.01.005_bib53","author":"Balcer"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib55","first-page":"132","article-title":"Unilateral straight hair and congenital Horner syndrome","volume":"32","author":"Wang","year":"2012","journal-title":"J\u00a0Neuro-Ophthalmol"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3988\/jcn.2015.11.2.192","article-title":"Congenital Horner syndrome with heterochromia iridis associated with ipsilateral internal carotid artery hypoplasia","volume":"11","author":"Deprez","year":"2015","journal-title":"J\u00a0Clin Neurol Seoul Korea"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0b013e32834bbf06","article-title":"Neuroimaging yield in isolated Horner syndrome","volume":"22","author":"Al-Moosa","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib58","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajo.2006.05.047","article-title":"Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions","volume":"142","author":"Mahoney","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9394(14)72848-X","article-title":"Fascicular arrangement in partial oculomotor paresis","volume":"118","author":"Ksiazek","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib60","first-page":"238","article-title":"Imaging of intracranial aneurysms causing isolated third cranial nerve palsy","volume":"29","author":"Chaudhary","year":"2009","journal-title":"J\u00a0Neuro Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bjo.87.4.510","article-title":"Tonic pupils from giant cell arteritis","volume":"87","author":"Foroozan","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib63","first-page":"54","article-title":"Orbital neural-glial hamartoma associated with a congenital tonic pupil","volume":"6","author":"Goldstein","year":"2002","journal-title":"J\u00a0AAPOS"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/01.WNL.0000148709.28743.E7","article-title":"Anti-Hu antibodies, sensory neuropathy, and Holmes-Adie syndrome in a patient with seminoma","volume":"64","author":"M\u00fcller","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9394(02)01959-1","article-title":"Tonic pupil and sarcoidosis","volume":"135","author":"Bowie","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib66","first-page":"1","article-title":"Autonomic disorders and the eye","volume":"25","author":"Toth","year":"2005","journal-title":"J\u00a0Neuro Ophthalmol"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2169\/internalmedicine.33.248","article-title":"Guillain-Barr\u00e9 syndrome with bilateral tonic pupils","volume":"33","author":"Anzai","year":"1994","journal-title":"Intern Med Tokyo Jpn"},{"issue":"11","key":"10.1016\/j.mcna.2021.01.005_bib68","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1986.03370110061018","article-title":"Anisocoria from jimsonweed","volume":"255","author":"Savitt","year":"1986","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1034\/j.1600-0420.2002.800319.x","article-title":"Accidental mydriasis from exposure to Angel\u2019s trumpet (Datura suaveolens)","volume":"80","author":"Havelius","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib71","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9394(14)72963-0","article-title":"A\u00a0prospective evaluation of cholinergic supersensitivity of the iris sphincter in patients with oculomotor nerve palsies","volume":"118","author":"Jacobson","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00041327-199809000-00004","article-title":"Comparison of cholinergic supersensitivity in third nerve palsy and Adie\u2019s syndrome","volume":"18","author":"Jacobson","year":"1998","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"12","key":"10.1016\/j.mcna.2021.01.005_bib73","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jamaophthalmol.2017.4508","article-title":"Diplopia-related ambulatory and emergency department visits in the United States, 2003-2012","volume":"135","author":"De Lott","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib74","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.eye.6702415","article-title":"Causes and outcomes for patients presenting with diplopia to an eye casualty department","volume":"21","author":"Comer","year":"2007","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MEJ.0b013e3283636120","article-title":"Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography","volume":"21","author":"Nazerian","year":"2014","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.mcna.2021.01.005_bib76","author":"Tamhankar"},{"issue":"3","key":"10.1016\/j.mcna.2021.01.005_bib77","first-page":"184","article-title":"Monocular diplopia. [Editorial]","volume":"6","year":"1986","journal-title":"J\u00a0Clin Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.mcna.2021.01.005_bib78","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000137045.33870.9E","article-title":"\u201cRetinal diplopia\u201d associated with macular wrinkling","volume":"63","author":"Barton","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mcna.2021.01.005_bib79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/aos.12062","article-title":"Acute-onset diplopia","volume":"92","author":"O\u2019Colmain","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.mcna.2021.01.005_bib80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0002-9394(14)74718-X","article-title":"Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear, and abducens cranial nerves","volume":"113","author":"Richards","year":"1992","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.mcna.2021.01.005_bib81","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.ophtha.2013.04.009","article-title":"Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study","volume":"120","author":"Tamhankar","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.mcna.2021.01.005_bib82","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/ICU.0000000000000200","article-title":"Management of acute cranial nerve 3, 4 and 6 palsies: role of neuroimaging","volume":"26","author":"Tamhankar","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.mcna.2021.01.005_bib83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/eye.2010.160","article-title":"Adult hypertropia: a guide to diagnostic evaluation based on review of 300 patients","volume":"25","author":"Tamhankar","year":"2011","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib84","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.survophthal.2005.12.008","article-title":"Skew deviation revisited","volume":"51","author":"Brodsky","year":"2006","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.mcna.2021.01.005_bib85","first-page":"455","article-title":"Internuclear ophthalmoplegia: pathophysiology and diagnosis","volume":"1","author":"Zee","year":"1992","journal-title":"Baillieres Clin Neurol"},{"issue":"9","key":"10.1016\/j.mcna.2021.01.005_bib86","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.WNL.0000123093.37069.6D","article-title":"Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction","volume":"62","author":"Kim","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.mcna.2021.01.005_bib87","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/S0161-6420(02)01118-1","article-title":"Prognosis of ischemic internuclear ophthalmoplegia","volume":"109","author":"Eggenberger","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mcna.2021.01.005_bib88","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The course of myasthenia gravis and therapies affecting outcome","volume":"505","author":"Grob","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mcna.2021.01.005_bib89","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajo.2019.04.017","article-title":"Incidence, epidemiology, and transformation of ocular myasthenia gravis: a population-based study","volume":"205","author":"Hendricks","year":"2019","journal-title":"Am J Ophthalmol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:34Z","timestamp":1758419134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0025712521000055"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.01.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-Ophthalmology for Internists","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}